Market Overview:
The global COVID-19 IgM/IgG antibody rapid test kits market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of COVID-19, rising awareness about early diagnosis and treatment of the disease, and technological advancements in diagnostic tests. The global COVID-19 IgM/IgG antibody rapid test kits market can be segmented on the basis of type into RDT (rapid diagnostic tests), ELISA (enzyme-linked immunosorbent assays), and neutralization assays. On the basis of application, this market can be segmented into hospitals, special clinics, research institutions, and others. Geographically, this market can be segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
COVID-19 IgM/IgG Antibody Rapid Test Kits are used to detect COVID-19 IgM and IgG antibodies in human serum or plasma. The kits are important for early diagnosis of COVID-19 infection.
RDT(Rapid Diagnostic Test):
The RDT is a rapid diagnostic test used for the detection of an infectious disease. It helps in determining the presence or absence of microorganisms, which can be used as a screening tool for COVID-19 positive patients.
ELISA(Enzyme-linked Immunosorbent Aassay):
ELISA is an immunoassay technique used for the detection of antibodies. It is commonly known as enzyme-linked immunosorbent assay or Enzyme-linked Immunosorbent Assay (ELISA). The ELISA technique measures the amount of antigen in a sample by using an antibody, which reacts with the antigen and creates a signal that can be detected by optical, electrochemical or biochemical methods.
Application Insights:
The hospital application segment led the global COVID-19 IgM/IgG antibody RDT market in 2017. This is attributed to the fact that this disease primarily affects immunocompromised patients and most of them are admitted in hospitals for diagnosis or treatment. As a result, an increasing number of individuals are being diagnosed with COVID-19, which boosts product demand at this segment.
Moreover, due to stringent government regulations regarding the safety of blood supply and usage, individuals who have been exposed to infected animals or people and have symptoms such as feverish state (temperature above 38°C) should immediately seek medical consultation without delay as they may be at risk from developing severe pneumonia along with other respiratory diseases. This factor also contributes toward product demand in hospital applications globally.
Regional Analysis:
North America dominated the global market in 2018 owing to the presence of a well-established healthcare infrastructure, high disposable income, and awareness regarding COVID-19 infection. Moreover, government initiatives for disease prevention and control are also expected to drive regional growth over the forecast period. For instance, in October 2018, CDC launched an emergency operation center for responding to novel influenza A virus infections called COVID-19 response team (CRT). The CRT is responsible for providing technical assistance related to rapid diagnostic tests as well as supporting laboratory testing throughout U.S.
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast period due its developing economy with increasing number of patients seeking treatment at private hospitals rather than government hospitals owing to lack of insurance coverage or financial burden associated with treatment at public facilities.
Growth Factors:
- Rising demand for COVID-19 IgM/IgG Antibody Rapid Test Kits from hospitals, clinics, and other healthcare institutions for early diagnosis of the disease
- Increasing number of outbreaks and pandemics of COVID-19 across the globe
- Growing awareness about COVID-19 and its early diagnosis among people
- Technological advancements in rapid test kits that offer accurate results within minutes
- Government initiatives to promote use of rapid test kits for early diagnosis of COVID-19
Scope Of The Report
Report Attributes
Report Details
Report Title
COVID-19 IgM/IgG Antibody Rapid Test Kits Market Research Report
By Type
RDT(Rapid Diagnostic Test), ELISA(Enzyme-linked Immunosorbent Aassay), Neutralization Assay
By Application
Hospital, Special Clinic, Research Institutions
By Companies
Cellex, RayBiotech, Biopanda, BioMedomics, GenBody, SD Biosensor, Advaite, Premier Biotech, Epitope Diagnostics, CTK Biotech, Creative Diagnostics, Eagle Biosciences, Sure Biotech, Sugentech, Sensing self, Euroimmun AG, PharmACT, Liming Bio, Beijing Wantai, Livzon Diagnostics, Shenzhen BioEasy Biotechnology, Orient Gene Biotech, INNOVITA, Dynamiker, Guangzhou Wonfo Bio-Tech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global COVID-19 IgM/IgG Antibody Rapid Test Kits Market Report Segments:
The global COVID-19 IgM/IgG Antibody Rapid Test Kits market is segmented on the basis of:
Types
RDT(Rapid Diagnostic Test), ELISA(Enzyme-linked Immunosorbent Aassay), Neutralization Assay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Special Clinic, Research Institutions
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cellex
- RayBiotech
- Biopanda
- BioMedomics
- GenBody
- SD Biosensor
- Advaite
- Premier Biotech
- Epitope Diagnostics
- CTK Biotech
- Creative Diagnostics
- Eagle Biosciences
- Sure Biotech
- Sugentech
- Sensing self
- Euroimmun AG
- PharmACT
- Liming Bio
- Beijing Wantai
- Livzon Diagnostics
- Shenzhen BioEasy Biotechnology
- Orient Gene Biotech
- INNOVITA
- Dynamiker
- Guangzhou Wonfo Bio-Tech
Highlights of The COVID-19 IgM/IgG Antibody Rapid Test Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- RDT(Rapid Diagnostic Test)
- ELISA(Enzyme-linked Immunosorbent Aassay)
- Neutralization Assay
- By Application:
- Hospital
- Special Clinic
- Research Institutions
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the COVID-19 IgM/IgG Antibody Rapid Test Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The COVID-19 IgM/IgG Antibody Rapid Test Kits are a rapid test for the detection of antibodies to coronavirus 19 (COVID-19).
Some of the key players operating in the covid-19 igm/igg antibody rapid test kits market are Cellex, RayBiotech, Biopanda, BioMedomics, GenBody, SD Biosensor, Advaite, Premier Biotech, Epitope Diagnostics, CTK Biotech, Creative Diagnostics, Eagle Biosciences, Sure Biotech, Sugentech, Sensing self, Euroimmun AG, PharmACT, Liming Bio, Beijing Wantai, Livzon Diagnostics, Shenzhen BioEasy Biotechnology, Orient Gene Biotech, INNOVITA, Dynamiker, Guangzhou Wonfo Bio-Tech.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 COVID-19 IgM/IgG Antibody Rapid Test Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the COVID-19 IgM/IgG Antibody Rapid Test Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size & Forecast, 2018-2028
4.5.1 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size and Y-o-Y Growth
4.5.2 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Absolute $ Opportunity
Chapter 5 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Type
5.2.1 RDT(Rapid Diagnostic Test)
5.2.2 ELISA(Enzyme-linked Immunosorbent Aassay)
5.2.3 Neutralization Assay
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Special Clinic
6.2.3 Research Institutions
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America COVID-19 IgM/IgG Antibody Rapid Test Kits Analysis and Forecast
9.1 Introduction
9.2 North America COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Type
9.6.1 RDT(Rapid Diagnostic Test)
9.6.2 ELISA(Enzyme-linked Immunosorbent Aassay)
9.6.3 Neutralization Assay
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Special Clinic
9.10.3 Research Institutions
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe COVID-19 IgM/IgG Antibody Rapid Test Kits Analysis and Forecast
10.1 Introduction
10.2 Europe COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Type
10.6.1 RDT(Rapid Diagnostic Test)
10.6.2 ELISA(Enzyme-linked Immunosorbent Aassay)
10.6.3 Neutralization Assay
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Special Clinic
10.10.3 Research Institutions
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific COVID-19 IgM/IgG Antibody Rapid Test Kits Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Type
11.6.1 RDT(Rapid Diagnostic Test)
11.6.2 ELISA(Enzyme-linked Immunosorbent Aassay)
11.6.3 Neutralization Assay
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Special Clinic
11.10.3 Research Institutions
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America COVID-19 IgM/IgG Antibody Rapid Test Kits Analysis and Forecast
12.1 Introduction
12.2 Latin America COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Type
12.6.1 RDT(Rapid Diagnostic Test)
12.6.2 ELISA(Enzyme-linked Immunosorbent Aassay)
12.6.3 Neutralization Assay
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Special Clinic
12.10.3 Research Institutions
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) COVID-19 IgM/IgG Antibody Rapid Test Kits Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Type
13.6.1 RDT(Rapid Diagnostic Test)
13.6.2 ELISA(Enzyme-linked Immunosorbent Aassay)
13.6.3 Neutralization Assay
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) COVID-19 IgM/IgG Antibody Rapid Test Kits Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Special Clinic
13.10.3 Research Institutions
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 COVID-19 IgM/IgG Antibody Rapid Test Kits Market: Competitive Dashboard
14.2 Global COVID-19 IgM/IgG Antibody Rapid Test Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cellex
14.3.2 RayBiotech
14.3.3 Biopanda
14.3.4 BioMedomics
14.3.5 GenBody
14.3.6 SD Biosensor
14.3.7 Advaite
14.3.8 Premier Biotech
14.3.9 Epitope Diagnostics
14.3.10 CTK Biotech
14.3.11 Creative Diagnostics
14.3.12 Eagle Biosciences
14.3.13 Sure Biotech
14.3.14 Sugentech
14.3.15 Sensing self
14.3.16 Euroimmun AG
14.3.17 PharmACT
14.3.18 Liming Bio
14.3.19 Beijing Wantai
14.3.20 Livzon Diagnostics
14.3.21 Shenzhen BioEasy Biotechnology
14.3.22 Orient Gene Biotech
14.3.23 INNOVITA
14.3.24 Dynamiker
14.3.25 Guangzhou Wonfo Bio-Tech
